Author details

Full Name

Farook Al-Azzawi

Affiliation

ORCID

Career Start Year

1984

Papers

125

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33982872	Folic acid supplementation in postmenopausal women with hot flushes: phase III randomised double-blind placebo-controlled trial.	BJOG: An International Journal of Obstetrics and Gynaecology	2021
30156935	Microsatellite variation of ESR1, ESR2, and AR in Serbian women with primary ovarian insufficiency.	Climacteric	2018
27568683	Post NICE Guidelines: could precision prescribing of estrogen be achieved?	Climacteric	2016
25966862	Use of the levonorgestrel intrauterine system in postmenopause.	Climacteric	2015
25527234	Transcription factor SOHLH1 potentially associated with primary ovarian insufficiency.	Fertility and Sterility	2015
25966864	Levonorgestrel and breast cancer risk - clarified.	Climacteric	2015
25242337	ISGE statement on oral emergency contraception.	Gynecological Endocrinology	2014
24103315	Ethnic specificity of variants of the ESR1, HK3, BRSK1 genes and the 8q22.3 locus: no association with premature ovarian failure (POF) in Serbian women.		2014
23805834	Lack of association between ESR1 gene polymorphisms and premature ovarian failure in Serbian women.	Climacteric	2014
24524832	Novel variants in the SOHLH2 gene are implicated in human premature ovarian failure.	Fertility and Sterility	2014
23638777	The clinical choice between estrogen and bisphosphonates to prevent bone loss: are women being misled?	Women's Health	2013
24167828	Measuring vulvovaginal symptoms in postmenopausal women.	Climacteric	2013
24127974	Acute presentation of clitoral phimosis in a 16-year-old girl.	Journal of Obstetrics and Gynaecology	2013
22171766	A modern approach to postmenopausal HRT: trading bleeding with safety.	Women's Health	2012
19958161	Therapeutic options for postmenopausal female sexual dysfunction.	Climacteric	2010
20840282	Effectiveness of phytoestrogens in climacteric medicine.	Annals of the New York Academy of Sciences	2010
20166859	Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.	Climacteric	2010
19702446	Report on the 8th European Congress on Menopause.	Women's Health	2009
19372016	Hormonal changes during menopause.		2009
19372015	Mechanism of androgen receptor action.		2009
18076706	Differential expression of oestrogen receptor isoforms and androgen receptor in the normal vulva and vagina compared with vulval lichen sclerosus and chronic vaginitis.	British Journal of Dermatology	2008
19031214	Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates.	Gynecological Endocrinology	2008
18562193	Differing transcriptional responses to pulsed or continuous estradiol exposure in human umbilical vein endothelial cells.	Journal of Steroid Biochemistry and Molecular Biology	2008
18184756	Changes in transcription profile and cytoskeleton morphology in pelvic ligament fibroblasts in response to stretch: the effects of estradiol and levormeloxifene.	Molecular Human Reproduction	2008
18088530	Prevention and treatment of osteoporosis in women.		2007
16556677	Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell.	Molecular Human Reproduction	2006
19803961	Current state of hormone replacement therapy: the case for using trimegestone.	Women's Health	2006
16364575	Which progestogen is more likely to increase the risk of fatal myocardial infarction: a combination of epidemiological and trial evidence.	Maturitas	2006
15889268	Quantitative histomorphometric analysis of gonadal steroid receptor distribution in the normal human endometrium through the menstrual cycle.	Histochemistry and Cell Biology	2005
15883103	Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.	Maturitas	2005
15879923	Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate.	Menopause	2005
15816354	Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer.	Experimental and Toxicologic Pathology	2005
16167959	The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders.	BJOG: An International Journal of Obstetrics and Gynaecology	2005
15142996	Changes in gonadal steroid receptors in the cardinal ligaments of prolapsed uteri: immunohistomorphometric data.	Human Reproduction	2004
15330680	17 beta-estradiol/levonorgestrel transdermal system. A viewpoint by Farook al-Azzawi.	Treatments in Endocrinology	2004
15270820	Nasal physiological changes during pregnancy.		2004
15541850	Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin.	European Journal of Obstetrics, Gynecology and Reproductive Biology	2004
15669554	Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.	Climacteric	2004
15223104	Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.	Maturitas	2004
15223101	The turbulent seas of women's health--who is the beneficiary?	Maturitas	2004
15008782	Questioning the ubiquity of outpatient endometrial sampling in the management of menstrual disorders.	BJOG: An International Journal of Obstetrics and Gynaecology	2004
15006250	Meningioma and hormonal influences.	Climacteric	2003
14679010	Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry.	Cancer Research	2003
12841882	Comparison of a novel vaginal ring delivering estradiol acetate versus oral estradiol for relief of vasomotor menopausal symptoms.	Climacteric	2003
14507843	Changes in extracellular matrix proteins in the cardinal ligaments of post-menopausal women with or without prolapse: a computerized immunohistomorphometric analysis.	Human Reproduction	2003
12895004	The distribution of estrogen receptor beta is distinct to that of estrogen receptor alpha and the androgen receptor in human skin and the pilosebaceous unit.	Journal of Investigative Dermatology Symposium Proceedings	2003
12892687	The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.	BJOG: An International Journal of Obstetrics and Gynaecology	2003
12702147	Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin.	Experimental Dermatology	2003
11980769	The effect of a change in the dose of trimegestone on the pattern of bleeding in estrogen-treated post-menopausal women: 6 month extension of a dose-ranging study.	Human Reproduction	2002
11974557	Estrogen and colon cancer: current issues.	Climacteric	2002